Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × nilotinib × Sarcoma × Clear all

Phase

Status

Completed 11 Terminated 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 7 Myeloid 4 Tumor-Agnostic 1 Sarcoma 1 Gynecologic 1 Gastrointestinal 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Cyclophosphamide 19 Nivolumab 17 Specimen Handling 16 Magnetic Resonance Spectroscopy 16 pembrolizumab 15 Radiotherapy 12 Doxorubicin 12 Biopsy 12 Temozolomide 11 Radiation 11 Ipilimumab 9 X-Rays 8 Etoposide 8 Bevacizumab 8 fludarabine 7 Sirolimus 7 Phantoms, Imaging 7 Irinotecan 7 Ifosfamide 7 cabozantinib 6 Carboplatin 6 palbociclib 5 olaparib 5 Radiosurgery 5 talimogene laherparepvec 4 regorafenib 4 pazopanib 4 fludarabine phosphate 4 durvalumab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡